An SCN9A channelopathy causes congenital inability to experience pain (original) (raw)

Nature volume 444, pages 894–898 (2006)Cite this article

Abstract

The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype. In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3. This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons. Sequence analysis of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X). We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells. In cells expressing mutant Nav1.7, the currents were no greater than background. Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans. These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Dearborn, G. A case of congenital general pure analgesia. J. Nerv. Ment. Dis. 75, 612–615 (1932)
    Article Google Scholar
  2. Dyck, P. J. et al. Not ‘indifference to pain’ but varieties of hereditary sensory and autonomic neuropathy. Brain 106, 373–390 (1983)
    Article PubMed Google Scholar
  3. Landrieu, P., Said, G. & Allaire, C. Dominantly transmitted congenital indifference to pain. Ann. Neurol. 27, 574–578 (1990)
    Article CAS PubMed Google Scholar
  4. Nagasako, E. M., Oaklander, A. L. & Dworkin, R. H. Congenital insensitivity to pain: an update. Pain 101, 213–219 (2003)
    Article PubMed Google Scholar
  5. Klein, C. J., Sinnreich, M. & Dyck, P. J. Indifference rather than insensitivity to pain. Ann. Neurol. 53, 417–418 (2003); author reply Ann. Neurol. 53, 418–419 (2003)
    Article Google Scholar
  6. Klugbauer, N., Lacinova, L., Flockerzi, V. & Hofmann, F. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J. 14, 1084–1090 (1995)
    Article CAS PubMed PubMed Central Google Scholar
  7. Toledo-Aral, J. J. et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc. Natl Acad. Sci. USA 94, 1527–1532 (1997)
    Article ADS CAS PubMed PubMed Central Google Scholar
  8. Sangameswaran, L. et al. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J. Biol. Chem. 272, 14805–14809 (1997)
    Article CAS PubMed Google Scholar
  9. Rush, A. M. et al. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc. Natl Acad. Sci. USA 103, 8245–8250 (2006)
    Article ADS CAS PubMed PubMed Central Google Scholar
  10. Amir, R. et al. The role of sodium channels in chronic inflammatory and neuropathic pain. J. Pain 7, S1–29 (2006)
    Article CAS PubMed Google Scholar
  11. Cummins, T. R., Howe, J. R. & Waxman, S. G. Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J. Neurosci. 18, 9607–9619 (1998)
    Article CAS PubMed PubMed Central Google Scholar
  12. Amrani, N., Sachs, M. S. & Jacobson, A. Early nonsense: mRNA decay solves a translational problem. Nature Rev. Mol. Cell Biol. 7, 415–425 (2006)
    Article CAS Google Scholar
  13. Black, J. A. et al. Spinal sensory neurons express multiple sodium channel α-subunit mRNAs. Brain Res. Mol. Brain Res. 43, 117–131 (1996)
    Article CAS PubMed Google Scholar
  14. Catterall, W. A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13–25 (2000)
    Article CAS PubMed Google Scholar
  15. Isom, L. L. Sodium channel β subunits: anything but auxiliary. Neuroscientist 7, 42–54 (2001)
    Article CAS PubMed Google Scholar
  16. Cummins, T. R., Dib-Hajj, S. D. & Waxman, S. G. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J. Neurosci. 24, 8232–8236 (2004)
    Article CAS PubMed PubMed Central Google Scholar
  17. Catterall, W. A., Goldin, A. L. & Waxman, S. G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57, 397–409 (2005)
    Article CAS PubMed Google Scholar
  18. Herzog, R. I., Cummins, T. R., Ghassemi, F., Dib-Hajj, S. D. & Waxman, S. G. Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons. J. Physiol. (Lond.) 551, 741–750 (2003)
    Article CAS Google Scholar
  19. Renganathan, M., Cummins, T. R. & Waxman, S. G. Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J. Neurophysiol. 86, 629–640 (2001)
    Article CAS PubMed Google Scholar
  20. Blair, N. T. & Bean, B. P. Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J. Neurosci. 22, 10277–10290 (2002)
    Article CAS PubMed PubMed Central Google Scholar
  21. Raymond, C. K. et al. Expression of alternatively spliced sodium channel α-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J. Biol. Chem. 279, 46234–46241 (2004)
    Article CAS PubMed Google Scholar
  22. Yang, Y. et al. Mutations in SCN9A, encoding a sodium channel α subunit, in patients with primary erythermalgia. J. Med. Genet. 41, 171–174 (2004)
    Article CAS PubMed PubMed Central Google Scholar
  23. Dib-Hajj, S. D. et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 128, 1847–1854 (2005)
    Article CAS PubMed Google Scholar
  24. Han, C. et al. Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann. Neurol. 59, 553–558 (2006)
    Article CAS PubMed Google Scholar
  25. Nassar, M. A. et al. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc. Natl Acad. Sci. USA 101, 12706–12711 (2004)
    Article ADS CAS PubMed PubMed Central Google Scholar
  26. Nassar, M. A., Levato, A., Stirling, L. C. & Wood, J. N. Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8. Mol. Pain 1, 24 (2005)
    Article PubMed PubMed Central Google Scholar
  27. Akopian, A. N., Abson, N. C. & Wood, J. N. Molecular genetic approaches to nociceptor development and function. Trends Neurosci. 19, 240–246 (1996)
    Article CAS PubMed Google Scholar
  28. Scholz, J. & Woolf, C. J. Can we conquer pain?. Nature Neurosci. 5, (Suppl)1062–1067 (2002)
    Article CAS PubMed Google Scholar

Download references

Acknowledgements

We thank the families who participated in this study, A. Boylston for critical advice, and Pfizer, the Wellcome Trust and St John’s College, Cambridge for funding. Author Contributions This study was designed by J.J.C., F.R., E.R., R.W., D.P.M., F.M.G. and C.G.W.; patient identification and phenotype assessment was performed by G.K., H.J., J.M., Y.R., L.A.-G., H.H., E.M.V., S.G. and C.G.W.; DNA extraction, linkage analysis, bioinformatics and sequencing was performed by J.J.C., A.K.N., E.R., K.S. and C.G.W.; cloning was performed by J.J.C.; electrophysiology was performed by F.R. and F.M.G.; and the paper was written by J.J.C., F.R., G.T., J.N.W., F.M.G. and C.G.W.

Author information

Author notes

  1. James J. Cox and Frank Reimann: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Medical Genetics,
    James J. Cox, Adeline K. Nicholas, Gemma Thornton & C. Geoffrey Woods
  2. Department of Clinical Biochemistry, Cambridge Institute for Medical Research, Wellcome/MRC Building, Addenbrooke’s Hospital, Cambridge, CB2 0XY, UK
    Frank Reimann & Fiona M. Gribble
  3. Section of Ophthalmology and Neuroscience Leeds Institute of Molecular Medicine,
    Emma Roberts & Kelly Springell
  4. Department of Clinical Genetics, St James’s University Hospital, Leeds, LS9 7TF, UK
    Gulshan Karbani
  5. Gene Tech Lab 146/1, Shadman Jail Road, Lahore, Pakistan
    Hussain Jafri
  6. Department of Paediatrics, Fatima Jinah Medical College, Lahore, Pakistan
    Jovaria Mannan
  7. Department of Obstetrics and Gynaecology, King Edward Medical University, Lahore, Pakistan
    Yasmin Raashid
  8. Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al-Anin, P O Box 15551, United Arab Emirates
    Lihadh Al-Gazali
  9. National Center for Diabetes, Endocrinology and Genetics, P O Box 3165/11942, Amman, Jordan
    Henan Hamamy
  10. IRCCS CSS, San Giovanni Rotondo and CSS Mendel, Rome, I-00168, Italy
    Enza Maria Valente
  11. Department of Paediatrics, St Luke’s Hospital, Bradford, BD5 0NA, UK
    Shaun Gorman
  12. Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, CT13 9NJ, UK
    Richard Williams & Duncan P. McHale
  13. Molecular Nociception Group, Department of Biology, University College London, London, WC1E 6BT, UK
    John N. Wood

Authors

  1. James J. Cox
    You can also search for this author inPubMed Google Scholar
  2. Frank Reimann
    You can also search for this author inPubMed Google Scholar
  3. Adeline K. Nicholas
    You can also search for this author inPubMed Google Scholar
  4. Gemma Thornton
    You can also search for this author inPubMed Google Scholar
  5. Emma Roberts
    You can also search for this author inPubMed Google Scholar
  6. Kelly Springell
    You can also search for this author inPubMed Google Scholar
  7. Gulshan Karbani
    You can also search for this author inPubMed Google Scholar
  8. Hussain Jafri
    You can also search for this author inPubMed Google Scholar
  9. Jovaria Mannan
    You can also search for this author inPubMed Google Scholar
  10. Yasmin Raashid
    You can also search for this author inPubMed Google Scholar
  11. Lihadh Al-Gazali
    You can also search for this author inPubMed Google Scholar
  12. Henan Hamamy
    You can also search for this author inPubMed Google Scholar
  13. Enza Maria Valente
    You can also search for this author inPubMed Google Scholar
  14. Shaun Gorman
    You can also search for this author inPubMed Google Scholar
  15. Richard Williams
    You can also search for this author inPubMed Google Scholar
  16. Duncan P. McHale
    You can also search for this author inPubMed Google Scholar
  17. John N. Wood
    You can also search for this author inPubMed Google Scholar
  18. Fiona M. Gribble
    You can also search for this author inPubMed Google Scholar
  19. C. Geoffrey Woods
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toC. Geoffrey Woods.

Ethics declarations

Competing interests

The sequence for full-length human SCN9A cloned from fetal brain mRNA is deposited in GenBank under accession number DQ857292. Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.

Supplementary information

Supplementary Information

This file contains Supplementary Methods discussing cloning methodology used to generate the constructs for this study, Supplementary Figures 1- 2 and Supplementary Tables 1-2. Supplementary Figure 1 shows kinetic properties of whole cell wild-type NaV1.7+NaVβ1+NaVβ2 currents in HEK293 cells. Supplementary Figure 2 shows alignment of the amino acid sequences of the corresponding common splice variants for the human (NP_002968) and mouse Nav1.7 (XP_904764) proteins using the LALIGN program (: = identical amino acid; . = similar amino acid). Supplementary Table 1 shows markers used to search for common haplotype blocks between the three families.Supplementary Table 2 shows primers used to amplify and sequence the coding exons and splice sites of SCN9A (PDF 5083 kb)

Rights and permissions

About this article

Cite this article

Cox, J., Reimann, F., Nicholas, A. et al. An SCN9A channelopathy causes congenital inability to experience pain.Nature 444, 894–898 (2006). https://doi.org/10.1038/nature05413

Download citation

Editorial Summary

A painless explanation

In a few individuals, a congenital condition leaves them completely insensitive to pain. Yet they have an apparently normal nervous system, have normal intelligence and enjoy good health. Apart, that is, from accidents and undetected injuries or infections. The mutation responsible has been mapped in a study of three families in northern Pakistan. The gene, SCN9A, was already known to be linked to pain perception: gain-of-function mutations cause pain hypersensitivity. SCN9A codes for a subunit of a voltage-gated sodium channel that is expressed in pain-sensing neurons. The fact that affected individuals are otherwise well raises the possibility that an agonist specific for this subunit might act as a 'total analgesic' with no side effects.

Associated content